Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Prevalence and Risk Factors of Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease

만성폐쇄성폐질환 환자에서 골다공증의 유병률과 위험인자

  • Sim, Yun Su (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Lee, Jin Hwa (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Ryu, Yon Ju (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Chun, Eun Mi (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Chang, Jung Hyun (Department of Internal Medicine, Ewha Womans University School of Medicine)
  • 심윤수 (이화여자대학교 의학전문대학원 내과학교실) ;
  • 이진화 (이화여자대학교 의학전문대학원 내과학교실) ;
  • 류연주 (이화여자대학교 의학전문대학원 내과학교실) ;
  • 천은미 (이화여자대학교 의학전문대학원 내과학교실) ;
  • 장중현 (이화여자대학교 의학전문대학원 내과학교실)
  • Received : 2009.01.22
  • Accepted : 2009.03.06
  • Published : 2009.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Osteoporosis is a significant comorbidity in patients with chronic obstructive pulmonary disease (COPD). This study examined the prevalence and risk factors associated with osteoporosis in patients with COPD. Methods: The bone mineral densities (BMDs) of the lumbar spine and femoral bone were measured in 53 patients with clinically stable COPD and 41 age- and gender-matched control subjects showing a normal lung function. Osteoporosis was defined as a T-score $\leq$-2.5. The subjects' clinical characteristics and laboratory data were reviewed, and multiple logistic regression analysis was used to identify the risk factors associated with osteoporosis in COPD patients. Results: The prevalence of osteoporosis was 47% and 32% in the COPD patients and controls, respectively. In particular, using the femoral neck T-score, the prevalence of osteoporosis in COPD patients was higher than that in the controls (26% vs. 5%; p=0.006). The average T-score of the lumbar spine (p=0.025) and femoral neck of COPD patients were significantly lower than those of the controls (p=0.001). The forced expiratory volume in the 1 second ($FEV_1$) % predicted (p=0.019; odds ratio [OR], 0.955; 95% confidence interval [CI], 0.919-0.993) and age (p=0.024; OR, 1.144; 95% CI, 1.018-1.287) were independently associated with osteoporosis in patients with COPD. Conclusion: Using the femoral neck T-score, the prevalence of osteoporosis in patients with COPD was higher than the age-and gender-matched controls. A lower $FEV_1$ and older age further increase the risk of osteoporosis in patients with COPD.

연구배경: 골다공증은 만성폐쇄성폐질환 환자의 중요한 동반질환 중 하나이다. 저자들은 COPD 환자에서 골다공증의 유병률과 위험인자를 알아 보고자 하였다. 방 법: 안정 상태인 COPD 환자 51명과 이들과 나이와 성별을 일치시킨 대조군 41명에서 요추골과 대퇴골의 골밀도를 측정하였다. 임상기록과 검사결과를 검토하여, COPD 환자에서 골다공의 위험인자를 분석하였다. 결 과: COPD 환자에서, T점수가 -2.5 이하인, 골다공증의 유병률은 47%였고, 대조군에서 32%였다. 특히 대퇴골목의 T점수를 기준으로 한 골다공증의 유병률은 COPD 환자에서 대조군에 비해 유의하게 높았다(26% vs. 5%; p=0.006). COPD 환자의 요추와(p=0.025) 대퇴골목의 평균 T 점수는 대조군보다 유의하게 낮았다(p=0.001). COPD 환자에서 $FEV_1$의 정상예측치에 대한 비율과(p=0.019; odds ratio [OR], 0.955; 95% confidence interval [CI], 0.919-0.993) 연령이 골다공증 발생과 관련된 독립적인 위험인자였다(p=0.024; OR, 1.144; 95% CI, 1.018-1.287). 결 론: COPD 환자에서 골다공증의 유병률은 연령과 성별을 일치시킨 대조군보다 높다. 특히 대퇴골의 T점수가 요추보다 COPD 환자와 대조군의 골밀도의 차이를 더 분명하게 보여 주었다. COPD 환자에서 $FEV_1$이 낮을수록, 나이가 많을수록 골다공증 발생 위험이 크게 증가한다.

Keywords

References

  1. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:549-55 https://doi.org/10.1513/pats.200709-148ET
  2. Incalzi RA, Caradonna P, Ranieri P, Basso S, Fuso L, Pagano F, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med 2000;94:1079-84 https://doi.org/10.1053/rmed.2000.0916
  3. Iqbal F, Michaelson J, Thaler L, Rubin J, Roman J, Nanes MS. Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest 1999;116:1616-24 https://doi.org/10.1378/chest.116.6.1616
  4. Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1996;101:262-9 https://doi.org/10.1016/S0002-9343(96)00155-6
  5. Block JE, Stubbs H. Hip fracture-associated mortality reconsidered. Calcif Tissue Int 1997;61:84 https://doi.org/10.1007/s002239900300
  6. Biskobing DM. COPD and osteoporosis. Chest 2002; 121:609-20 https://doi.org/10.1378/chest.121.2.609
  7. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76 https://doi.org/10.1164/ajrccm.163.5.2101039
  8. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995;152: 1107-36 https://doi.org/10.1164/ajrccm.152.3.7663792
  9. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-41 https://doi.org/10.1002/jbmr.5650090802
  10. Jorgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 2007;101:177-85 https://doi.org/10.1016/j.rmed.2006.03.029
  11. Slemenda CW, Hui SL, Longcope C, Johnston CC Jr. Cigarette smoking, obesity, and bone mass. J Bone Miner Res 1989;4:737-41 https://doi.org/10.1002/jbmr.5650040513
  12. Daniell HW. Osteoporosis and smoking. JAMA 1972;221:509 https://doi.org/10.1001/jama.221.5.509
  13. Bassett CA, Becker RO. Generation of electric potentials by bone in response to mechanical stress. Science 1962;137:1063-4 https://doi.org/10.1126/science.137.3535.1063
  14. Cauley JA, Salamone LM, Lucas FL. Postmenopausal endogenous and exogenous hormones, degree of obesity, thiazide diuretics, and risk of osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. 1st ed. New York: Academic Press; 1996. p. 551-76
  15. Adachi JD. Corticosteroid-induced osteoporosis. Am J Med Sci 1997;313:41-9 https://doi.org/10.1097/00000441-199701000-00007
  16. Lane NE, Lukert B. The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am 1998;27:465-83 https://doi.org/10.1016/S0889-8529(05)70017-7
  17. Canalis E. Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996;81:3441-7 https://doi.org/10.1210/jc.81.10.3441
  18. Sevenoaks MJ, Stockley RA. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype? Respir Res 2006;7: 70 https://doi.org/10.1186/1465-9921-7-70
  19. Dalsky GP, Stocke KS, Ehsani AA, Slatopolsky E, Lee WC, Birge SJ Jr. Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women. Ann Intern Med 1988;108:824-8 https://doi.org/10.7326/0003-4819-108-6-824
  20. White MK, Martin RB, Yeater RA, Butcher RL, Radin EL. The effects of exercise on the bones of postmenopausal women. Int Orthop 1984;7:209-14
  21. Choi JS, An KC, Lee CS, Choi JM, Kim JY, Shin DR. DEXA T-score concordance and discordance between hip and lumbar spine. J Korean Soc Spine Surg 2003;10:75-81 https://doi.org/10.4184/jkss.2003.10.2.75